作者
Ying Cheng,David R. Spigel,Byoung Chul Cho,К. К. Лактионов,Jian Fang,Yuanbin Chen,Yoshitaka Zenke,Ki Hyeong Lee,Qiming Wang,Alejandro Navarro,Reyes Bernabé,E.L. Buchmeier,John Wen-Cheng Chang,Yoshimasa Shiraishi,Sema Sezgin Göksu,A. Badzio,Anhui Shi,Davey B. Daniel,Nguyễn Thị Thái Hòa,Milada Zemanová,Helen Mann,Hema Gowda,Haiyi Jiang,Suresh Senan
摘要
Adjuvant therapy with durvalumab, with or without tremelimumab, may have efficacy in patients with limited-stage small-cell lung cancer who do not have disease progression after standard concurrent platinum-based chemoradiotherapy.